• Report Adverse Event or Product Quality Complaint
  • US Site
  • Global Site
AstraZeneca Medical Information
  • Therapy Areas
    • All Therapeutic Areas
    • Cardiovascular
    • Immunology
    • Infection
    • Metabolic
    • Oncology
    • Renal
    • Respiratory
    • Rare Disease (Alexion)
  • Medications
  • Resources
    • Congress Library
    • Disease Education
    • Pipeline
    • Clinical Trials
    • Open innovation
    • Access 360
    • Affordability Programs
    • Sample Closet
    • Medical Education Grant
    • Rare Disease (Alexion)
  • Connect
    • Connect with Us
    • Find an MSL
    • Request an MSL
    • Submit an MIR
    • Give Feedback
User
  • Login to My AZmedical
  • Register for My AZmedical

Search Medical Information

Cardiovascular

AstraZeneca is pleased to present healthcare professionals with a variety of cardiovascular resources for your informational purposes.The educational materials are intended to provide information that can assist you in forming your own clinical and treatment decisions.

  1. Congress Library
  2. Medications
  3. Disease Education
  4. Continuing Education
  5. Pipeline

pipeline

November 12-15, 2023

International Society for Pharmacoeconomics and Outcomes Research - 26th Annual European Congress

Explore AstraZeneca Scientific Materials Visit website

November 10-13, 2023

American Heart Association Scientific Sessions 2023

Explore AstraZeneca Scientific Materials Visit website

August 25-28, 2023

European Society of Cardiology (ESC) Annual Congress 2023

Explore AstraZeneca Scientific Materials Visit website

June 24 - 28, 2023

International Society on Thrombosis and Haemostasis (ISTH) Congress 2023

Explore AstraZeneca Scientific Materials Visit website

April 11-15, 2023

National Kidney Foundation: Spring Clinical Meetings 23

Explore AstraZeneca Scientific Materials Visit website

March 4-6, 2023

American College of Cardiology - ACC 2023

Explore AstraZeneca Scientific Materials Visit website

This page provides access to AstraZeneca presentations and posters shared during the congresses listed below. Content availability is subject to the timeliness and permissions outlined by respective congresses.

ESH 2025

European Society of Hypertension

 

May 23 - 26, 2025

Visit website

 

 

ESC-HF HFA 2025

European Society of Cardiology-Heart Failure: Heart Failure Association

 

May 17 - 20, 2025

Visit website

 

 

ACC 2025

American College of Cardiology

 

March 29 - 31, 2025

Visit website

 

 

AHA 2024

American Heart Association (AHA 2024)

 

November 16 - 18, 2024

Visit website

 

 

ESC 2024

European Society of Cardiology

 

August 30 - September 02, 2024

Visit website

 

 

ISA 2024

International Society of Amyloidosis

 

May 26 - 30, 2024

Visit website

 

 

ESC-HF HFA 2024

European Society of Cardiology-Heart Failure: Heart Failure Association

 

May 11 - 14, 2024

Visit website

 

 

  • ANDEXXA<sup>®</sup> (coagulation factor Xa (recombinant), inactivated-zhzo) Lyophilized powder for solution for intravenous injection
  • BRILINTA<sup>®</sup> (ticagrelor) Tablets
  • CRESTOR<sup>®</sup> (rosuvastatin calcium) Tablets
  • FARXIGA<sup>®</sup> (dapagliflozin) Tablets
  • WAINUA<sup>™</sup> (eplontersen)
  • Aldosterone Dysregulation and Hypertension Explore Aldosterone Dysregulation and Hypertension
  • Other Cardiovascular Diseases Explore Other Cardiovascular Diseases
  • Transthyretin-mediated Amyloidosis (ATTR) Explore Transthyretin-mediated Amyloidosis (ATTR)

Email Recipient

  1. Colleague
  2. Myself

e-Learning

Addressing Challenges: Best Practices for DOAC Reversal in Intracranial Hemorrhage

Voxmedia LLC

15-Oct-2024 to 31-Oct-2025

Online enduring material

Learn More

e-Learning

Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)

Voxmedia LLC

13-Dec-2024 to 13-Dec-2025

Online enduring material

Learn More

e-Learning

Updates in Anticoagulation Reversal

International Society on Thrombosis and Haemostasis

24-Jun-2024 to 30-Jul-2025

Content and educational materials which will be available in a variety of formats and will cover expert analysis of recent data and information on anticoagulation reversal therapies. 

Learn More

 

 

e-Learning

Insights into Transthyretin Amyloid Polyneuropathy (ATTR-PN): From Basic Science to Best Patient Care

Voxmedia LLC

26-Jun-2024 to 26-Jun-2025

Online CME Enduring Material

Learn More

e-Learning

Best Practices for Managing Intracerebral Hemorrhage

Voxmedia LLC

14-Mar-2025 to 14-Mar-2026

Online video enduring material

Learn More

e-Learning

Podcast

Association of Black Cardiologists, Inc.

15-Nov-2024 to 15-Nov-2025

CME Enduring Podcast 

Learn More

e-Learning

Webcast

Association of Black Cardiologists, Inc.

25-Nov-2024 to 24-Nov-2025

CME Enduring Webcast 

Learn More

e-Learning

Deep Dive into Five

Association of Black Cardiologists, Inc.

01-Dec-2024 to 01-Dec-2025

Webcast/Podcast review live program information

Learn More

e-Learning

TTRansforming the TTReatment of ATTR: Pathophysiology, Diagnosis, and Emerging Treatment Strategies for Hereditary Transthyretin Cardiac Amyloidosis

PVI, PeerView Institute for Medical Education, Inc.

24-Oct-2024 to 23-Oct-2025

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Web What’s New in Treating the Anticoagulated Patient with ICH?

TotalCME

07-Jun-2024 to 07-Jun-2025

Enduring activity derived from live symposium held on 05/15/24 

Learn More

e-Learning

Live web Improving Outcomes of Patients With Transthyretin Amyloid Polyneuropathy (ATTR-PN)

Voxmedia LLC

15-Oct-2024 to 15-Oct-2025

1 hour 15 minute webinar on CMEPlanet.com and YouTube CMEPlanet Channel and 1 hour 15 minute enduring material hosted on CMEPlanet.com

Learn More

e-Learning

Web enduring Improving Outcomes of Patients With Transthyretin Amyloid Polyneuropathy (ATTR-PN)

Voxmedia LLC

15-Oct-2024 to 31-Oct-2025

Online enduring material

Learn More

e-Learning

Improving Outcomes for Patients With HR+/HER2- Advanced Breast Cancer

PRIME Education, LLC

22-May-2025 to 21-May-2026

1.0-hour Enduring Webcast with Downloadable HR+/HER2- Advanced Breast Cancer Pocket Guide

Learn More

e-Learning

Transformation in the Transthyretin Amyloid Polyneuropathy Treatment Landscape

Plexus Communications LLC

14-Apr-2025 to 14-Apr-2026

This enduring CME activity is designed to equip neurologists and allied healthcare professionals with the latest clinical insights into hereditary transthyretin amyloid polyneuropathy (ATTRv-PN). 

Learn More

e-Learning

TTRemendous Advances in Transthyretin Amyloidosis Treatment: What Neurologists Need to Know

PVI, PeerView Institute for Medical Education, Inc.

16-Jul-2024 to 15-Jul-2025

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

Request a field medical follow-up

Welcome to AstraZeneca
Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.

This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.

Are you a healthcare professional practicing in the United States?

I am an AstraZeneca authorized person   What is an AstraZeneca authorized person?This website is only intended for healthcare professionals practicing in the United States and authorized AstraZeneca personnel. AstraZeneca US Headquarters personnel and US Field Medical personnel are authorized to browse and search the database for their own background knowledge and insight. US Field Sales personnel should not access or browse this site. None of the content of this site should be directly linked or distributed without approval.
I am a payer or formulary decision-maker
I am neither (take me to AstraZeneca.com)
AstraZeneca Logo
Pharma Logo

This site is intended for healthcare professionals practicing in the US.

©2022 AstraZeneca. All rights reserved.

US-69609

Last Updated 11/22

Contact Us

About Us

AstraZeneca-US.com

Grant Opportunities

Survey Feedback

Your Privacy Choices

Privacy Notice

Legal Notice

Cookie Notice

US Site

Global Site

Report Adverse Event or Product Quality Complaint

Pharma Logo

Privacy NoticeLegal NoticeCookie Notice